Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMc Mining Regulatory News (MCM)

Share Price Information for Mc Mining (MCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 7.50
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 1.00 (13.333%)
Open: 8.00
High: 8.00
Low: 8.00
Prev. Close: 8.00
MCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

3 Jun 2015 12:00

RNS Number : 0735P
Coal of Africa Limited
03 June 2015
 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

Coal of Africa Limited

 

ABN

98 008 905 388

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

(a) Shares

(b) Unlisted Options

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

(a) 144,000,000 Shares

(b) 40,000,000 Unlisted Options

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

(a) Fully paid ordinary

 

(b) 40,000,000 Options exercisable on or before 1 June 2016 at an exercise price of ZAR0.3, vesting immediately

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

(a) Yes

 

(b) No

 

 

Options over unissued shares may only be exercised in accordance with their terms and conditions. Upon conversion of the options to shares, the shares will rank equally with existing shares.

 

 

 

5

Issue price or consideration

 

(a) GBP 7.92 million at an agreed value of GBP 0.055 per share as per the Subscription Agreements entered into between the Placees and the Company on or about 26 August 2014 (and subsequently amended on or about 17 December 2014)

 

(b) Nil

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

(a) Private placement to settle various liabilities and meet working capital requirements.

 

(b) Private placement of Options issued to TMM (Pty) Ltd

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

N/A

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Rule 7.1 - 55,705,291 shares

 

Rule 7.1A - N/A

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

3 June 2015

 

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

1,743,568,613

Ordinary shares

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

1,441,061

 

 

 

2,500,000

 

 

 

3,500,000

 

 

 

2,670,000

 

 

 

3,932,928

 

 

 

4,125,000

 

 

 

40,000,000

 

ESOP Options exercisable at A$1.40 on or before 30 September 2015

 

Class C Options exercisable at A$1.20 on or before 9 November 2015

 

Class L Options exercisable at 25 pence on or before 30 November 2015

 

ESOP Options exercisable at ZAR7.60 on or before 14 February 2017

 

ESOP Options exercisable at ZAR 1.75 on or before 30 June 2017

 

ESOP Options exercisable at ZAR 2.0 on or before 30 June 2018

 

Options exercisable at ZAR0.3 on or before 1 June 2016

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

N/A

 

12

Is the issue renounceable or non-renounceable?

 

 

13

Ratio in which the +securities will be offered

 

 

14

+Class of +securities to which the offer relates

 

 

15

+Record date to determine entitlements

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

 

 

17

Policy for deciding entitlements in relation to fractions

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

 

 

19

Closing date for receipt of acceptances or renunciations

 

 

 

 

 

 

20

Names of any underwriters

 

 

 

 

21

Amount of any underwriting fee or commission

 

 

22

Names of any brokers to the issue

 

 

 

 

23

Fee or commission payable to the broker to the issue

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 

 

28

Date rights trading will begin (if applicable)

 

 

29

Date rights trading will end (if applicable)

 

 

30

How do security holders sell their entitlements in full through a broker?

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

 

 

33

+Issue date

 

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

+Securities described in Part 1 (a) only

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

N/A

 

 

 

39

+Class of +securities for which quotation is sought

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ......................................................... Date: 3 June 2015

Company secretary

Print name: Tony Bevan

== == == == ==

 

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

1,048,368,613

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

 

 

551,000,000

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

Nil

"A"

1,599,368,613

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

239,905,291

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

144,200,000 shares

40,000,000 unlisted options

 

 

"C"

184,200,000

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

239,905,291

Subtract "C"

Note: number must be same as shown in Step 3

 

184,200,000

Total ["A" x 0.15] - "C"

55,705,291

 [Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

N/A

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

N/A

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

"E"

N/A

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

Subtract "E"

Note: number must be same as shown in Step 3

Total ["A" x 0.10] - "E"

N/A

Note: this is the remaining placement capacity under rule 7.1A

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEKDEEASEFF
Date   Source Headline
30th Apr 202410:15 amRNSRECEIPT OF SHAREHOLDER NOTICE
30th Apr 20249:31 amRNSAppendix 5B
30th Apr 20249:30 amRNSACTIVITIES REPORT FOR THE QUARTER ENDED 31 MAR 24
25th Apr 20242:00 pmRNSDirectorate Change
23rd Apr 20247:00 amRNSChange in substantial holding
22nd Apr 20247:00 amRNSChange in substantial holding
19th Apr 20248:16 amRNSResignation of Independent Non-Executive Director
18th Apr 20249:00 amRNSGoldway - Sixth Supplementary Bidder's Statement
15th Apr 20247:24 amRNSGoldway - Fifth supplementary bidder's statement
15th Apr 20247:00 amRNSChange in substantial holding
10th Apr 20248:00 amRNSResponse to Offer Being Declared Unconditional
8th Apr 20247:00 amRNSNotice of Variation of Unconditional Offer
8th Apr 20247:00 amRNSSatisfaction of Minimum Acceptance Condition
5th Apr 20247:00 amRNSGoldway - Notice of Status of Defeating Conditions
5th Apr 20247:00 amRNSChange in substantial holding
4th Apr 20244:30 pmRNSExtension of Offer Period for Off-Market Takeover
4th Apr 20247:00 amRNSGoldway - Notice of Extension of Offer Period
3rd Apr 202411:00 amRNSResponse to 4th Supplementary Bidder's Statement
2nd Apr 20247:00 amRNSChange in substantial holding
28th Mar 20247:00 amRNSGoldway - Fourth supplementary bidder's statement
25th Mar 20248:49 amRNSResponse to 3rd Supplementary Bidder's Statement
22nd Mar 20247:00 amRNSGoldway Capital Investment - Status of Conditions
22nd Mar 20247:00 amRNSChange in substantial holding
21st Mar 20247:00 amRNSGoldway - Third supplementary bidder's statement
20th Mar 20241:01 pmRNSResponse to 2nd Supplementary Bidder's Statement
19th Mar 20247:01 amRNSChange in substantial holding
18th Mar 20247:33 amRNSSupplementary Target's Statement - DO NOT ACCEPT
15th Mar 202410:15 amRNSInterim Financial Report
15th Mar 20249:41 amRNSHalf-year Results
14th Mar 20249:51 amRNSSecond Bidder's Statement - Do Not Accept
12th Mar 20247:19 amRNSOffer Update
8th Mar 20249:31 amRNSNon-Binding Indicative Offer from Vulcan Resources
4th Mar 20247:00 amRNSChange in substantial holding
4th Mar 20247:00 amRNSRelease of Target Statement
19th Feb 20247:00 amRNSGoldway Capital - Dispatch of Bidder's Statement
15th Feb 20248:04 amRNSOff-Market Takeover Bid - Do NOT Accept the Offer
15th Feb 20247:00 amRNSGoldway Capital - Supplementary Bidder's Statement
2nd Feb 202411:30 amRNSTakeover Bid - Receipt of Bidder's Statement
2nd Feb 20247:00 amRNSGoldway Capital Investment - Bidder's Statement
31st Jan 20248:45 amRNSAppendix 5B
31st Jan 20248:40 amRNSActivities Report for the Quarter ended 31 Dec 23
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.